News and Insights of 3D Printing and Manufacturing
HomeMedical
Researchers from Nottingham Trent University (NTU) have developed realistic 3D printed heart and lung models that can bleed, beat and breathe like their real counterparts.
A recent collaboration between researchers at the University of Oregon (UO) and L’Oréal has resulted in the development of a multilayered artificial skin model, designed to resemble the complexity of real human skin closely.
Ceramic tools show their potential where metal devices start to fail, with ceramics increasingly becoming the material of choice in many medical tools. Not only are they extremely heat and wear-resistant, they are also perfectly biocompatible and can be easily sterilized.
North Carolina-based medical 3D printing startup Phase has secured a $1.8 million grant from the National Institutes of Health (NIH) to advance its work in 3D printing technology for microfluidic organ-on-a-chip models.
Following the success of a breakthrough eye transplant, Belgian 3D printing company Materialise has introduced its latest solution to treat patients requiring total temporomandibular joint (TMJ) arthroplasty.
US-based 3D printer manufacturer 3D Systems has launched its new multi-material 3D printed denture offering. This is being advertised as the industry’s first solution for multi-material, jetted, and monolithic (one-piece) 3D printed dentures.
Desktop Health, the healthcare business unit of Massachusetts-based industrial 3D printer manufacturer Desktop Metal (DM) has announced a new formulation of its Flexcera resin for 3D printing gingiva.
Following its partnership with Airbus, metal AM company AddUp has collaborated with medical device startup Anatomic Implants to submit a 510(K) application for what the company claims to be the world’s first 3D printed toe joint replacement.
Austrian ceramic 3D printing company Lithoz will present the next development stage of its lithium disilicate material for dental 3D printing at LMT Lab Day Chicago 2024.
Chinese drug 3D printing firm Triastek has announced that its T22 3D printed gastric retention product has become the first drug of its kind to receive Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA).